Pathological mutations promote proteolysis of mitochondrial tRNA-specific 2-thiouridylase 1 (MTU1) via mitochondrial caseinolytic peptidase (CLPP)
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkad1197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Raja Norazireen Raja Ahmad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, 860-8556, Japan. Hauptthemen laut MEDLINE: Mitochondria, Peptide Hydrolases, tRNA Methyltransferases, Mitochondrial Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS, ERATO, FOREST.
Abstract (Originalsprache)
MTU1 controls intramitochondrial protein synthesis by catalyzing the 2-thiouridine modification of mitochondrial transfer RNAs (mt-tRNAs). Missense mutations in the MTU1 gene are associated with life-threatening reversible infantile hepatic failure. However, the molecular pathogenesis is not well understood. Here, we investigated 17 mutations associated with this disease, and our results showed that most disease-related mutations are partial loss-of-function mutations, with three mutations being particularly severe. Mutant MTU1 is rapidly degraded by mitochondrial caseinolytic peptidase (CLPP) through a direct interaction with its chaperone protein CLPX. Notably, knockdown of CLPP significantly increased mutant MTU1 protein expression and mt-tRNA 2-thiolation, suggesting that accelerated proteolysis of mutant MTU1 plays a role in disease pathogenesis. In addition, molecular dynamics simulations demonstrated that disease-associated mutations may lead to abnormal intermolecular interactions, thereby impairing MTU1 enzyme activity. Finally, clinical data analysis underscores a significant correlation between patient prognosis and residual 2-thiolation levels, which is partially consistent with the AlphaMissense predictions. These findings provide a comprehensive understanding of MTU1-related diseases, offering prospects for modification-based diagnostics and novel therapeutic strategies centered on targeting CLPP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, 860-8556, Japan.
- Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
- Center for Computational Sciences, University of Tsukuba, Tsukuba, Ibaraki, 305-8577, Japan.
ORCID-Profile: Takeshi Chujo, Kazuhito Tomizawa, Fan-Yan Wei
Förderung
- JSPS
- ERATO
- FOREST
- Takeda Science Foundation
- Uehara Memorial Foundation
- JST
Zitieren
APA
Ahmad, R. N. R., Zhang, L. T., Morita, R., Tani, H., Wu, Y., Chujo, T., Ogawa, A., Harada, R., Shigeta, Y., Tomizawa, K., & Wei, F. Y. (2024). Pathological mutations promote proteolysis of mitochondrial tRNA-specific 2-thiouridylase 1 (MTU1) via mitochondrial caseinolytic peptidase (CLPP). Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1197
Vancouver
Ahmad RNR, Zhang LT, Morita R, Tani H, Wu Y, Chujo T, et al. Pathological mutations promote proteolysis of mitochondrial tRNA-specific 2-thiouridylase 1 (MTU1) via mitochondrial caseinolytic peptidase (CLPP). Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1197
BibTeX
@article{Ahmad2024,
author = {Ahmad, Raja Norazireen Raja and Zhang, Long-Teng and Morita, Rikuri and Tani, Haruna and Wu, Yong and Chujo, Takeshi and Ogawa, Akiko and Harada, Ryuhei and Shigeta, Yasuteru and Tomizawa, Kazuhito and Wei, Fan-Yan},
title = {Pathological mutations promote proteolysis of mitochondrial tRNA-specific 2-thiouridylase 1 (MTU1) via mitochondrial caseinolytic peptidase (CLPP)},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkad1197}
}
EUVIMED